These findings indicate that in CFs, HGF blocks the TGF-β1-induced nuclear translocation of phospho-Smad2 and phospho-Smad3, inhibiting CF proliferation, differentiation and secretion. The gene discussed is SMAD2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.